Vaccines increase the risk of relapses in neuromyelitis optica spectrum disorder among untreated patients

被引：0
|
作者：
Mealy, M. A. [1 ]
Cook, L. J. [2 ]
Pache, F. [3 ]
Velez, D. L. [4 ]
Borisow, N. [3 ]
Becker, D. [1 ,5 ]
Arango, J. A. Jimenez [4 ]
Paul, F. [3 ]
Levy, M. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Neurol, Baltimore, MD USA
[2] Univ Utah, Sch Med, Pediat, Salt Lake City, UT USA
[3] Charite Univ Med Berlin, Neurol, Berlin, Germany
[4] Neuroclinica, Neurol, Medellin, Colombia
[5] Int Neurorehabil Inst, Lutherville Timonium, MD USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P496
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [21] Depression in patients with neuromyelitis optica spectrum disorder
    Seok, J. M.
    Choi, M.
    Kim, Y. S.
    Cho, E. B.
    Lee, H. L.
    Kang, S. -Y.
    Lee, K. H.
    Kim, B. J.
    Min, J. -H.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 94 - 94
  • [22] The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Hyun, Jae-Won
    Park, Boram
    Joo, Jungnam
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (14) : 1908 - 1911
  • [23] Immunoadsorption in patients with neuromyelitis optica spectrum disorder
    Faissner, Simon
    Nikolayczik, Johanna
    Chan, Andrew
    Gold, Ralf
    Yoon, Min-Suk
    Haghikia, Aiden
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2016, 9 (04) : 281 - 286
  • [24] Urosepsis Risk in Neuromyelitis Optica Spectrum Disorder Patients Administered Satralizumab
    Fujita, Rina
    Aratake, Yuriko
    Nakata, Kyoko
    Fujii, Chihiro
    Kondo, Takayuki
    INTERNAL MEDICINE, 2023, 62 (22) : 3317 - 3320
  • [25] Fall frequency and risk factors in patients with neuromyelitis optica spectrum disorder
    Barzegar, M.
    Mirmosayyeb, O.
    Azarbayejani, R.
    Brand, S.
    Afshari-Safavi, A.
    Shaygannejad, V.
    Bahmani, D. Sadeghi
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 459 - 460
  • [26] Severe Relapses of Neuromyelitis Optica Spectrum Disorder During Treatment With Dimethyl Fumarate
    Javadian, Nina
    Magrouni, Hana
    Ghaffarpour, Majid
    Ranji-Burachaloo, Sakineh
    CLINICAL NEUROPHARMACOLOGY, 2021, 44 (01) : 21 - 22
  • [27] Neuromyelitis Optica Spectrum Disorder
    Wingerchuk, Dean M.
    Lucchinetti, Claudia F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (07): : 631 - 639
  • [28] Patients with neuromyelitis optica spectrum disorder who experience relapses take more chronic pain medication
    Clardy, S.
    Kadish, R.
    Tanvir, I.
    Parker, T.
    Biskupiak, J.
    Kielhorn, A.
    Royston, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 473 - 473
  • [29] Earlier Treatment of Acute Relapses in Neuromyelitis Optica Spectrum Disorder Leads to Better Outcomes
    Coleman, Jessica
    Ng, Jennifer
    Mealy, Maureen
    Levy, Michael
    NEUROLOGY, 2017, 88
  • [30] Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy
    Ma, Xiaoyu
    Kermode, Allan G.
    Hu, Xueqiang
    Qiu, Wei
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
12345